FDA 510(k) Pending

NeuralRad
Brain

AI-Powered Stereotactic Radiosurgery Platform

Revolutionizing brain metastasis treatment with automated lesion detection, segmentation, and multi-course tracking. Built for radiation oncologists who demand precision.

Try Live Demo Learn More

Email hao.jiang@neuralrad.com to request demo credentials

<30s

Auto Segmentation

Visualization

Multi

Course Tracking

NeuralRad Brain - Automated brain metastasis segmentation with 3D visualization

Intelligent Radiosurgery Workflow

End-to-end AI assistance from detection to treatment planning

Auto Segmentation & Labeling

Deep learning-powered automatic detection and contouring of brain metastases with anatomical labeling. Reduce manual contouring time from hours to seconds.

Treatment Session Grouping

Intelligent lesion grouping into optimized treatment sessions based on proximity, dose constraints, and clinical priorities.

Longitudinal Lesion Tracking

Side-by-side comparison of lesions across multiple imaging timepoints with crosshair alignment for precise treatment response evaluation.

Volume Trend Analysis

Automated volume measurements with trend charts to quantify treatment response, detect progression, and support clinical decision-making.

Multi-Course Tracking

Seamlessly manage patients across multiple treatment courses with comprehensive study tracking and comparison tools.

Dose Map Visualization

Advanced dose distribution overlay with customizable colormaps for precise treatment verification and quality assurance.

Patient Notes & Collaboration

Document clinical findings with integrated patient notes, share annotated imaging studies, and coordinate with your care team through secure links.

Proven in Clinical Practice

Trusted by leading academic medical centers for routine patient care

UT Southwestern Medical Center

Dallas, Texas

Deployed for routine clinical use in the Department of Radiation Oncology, supporting stereotactic radiosurgery treatment planning for brain metastasis patients.

Active — Routine Clinical Use

Stanford Hospital

Stanford, California

Integrated into the radiation oncology clinical workflow, enabling automated lesion segmentation, multi-course tracking, and treatment response monitoring.

Active — Routine Clinical Use

Modern Architecture

Built with performance and security in mind

WebAssembly-powered 2D/3D medical image viewer
Svelte.js frontend for responsive user experience
Rust + WASM backend for near-native performance
AI processing with mU-Net segmentation and registration
DICOM and NIfTI format support
SQLite database with REST API

Our Vision

Replacing whole brain radiotherapy with stereotactic radiosurgery

We believe every patient with brain metastases deserves targeted, precise treatment. NeuralRad Brain makes stereotactic radiosurgery accessible and efficient for all radiation oncology centers.

Better Outcomes

Superior treatment results through precise tumor targeting

Quality of Life

Minimize cognitive side effects by sparing healthy brain tissue

Tumor Control

Higher local control rates compared to whole brain radiation

Survival

Improved long-term survival rates with targeted approach

Funded by the U.S. Government

Supported by NIH SBIR Phase I & Phase II contracts since 2021

Phase I

NIH SBIR Phase I

Initial research and feasibility study for AI-powered stereotactic radiosurgery workflow automation, awarded 2021.

Phase II

NIH SBIR Phase II

Advanced development and clinical validation of the NeuralRad Brain platform, enabling deployment at major academic medical centers.

NIH I-Corps Program — #1 Ranked Team

NeuralRad joined the NIH I-Corps program in 2021 and scored #1 out of all 20 teams. NIH has since confirmed that NeuralRad holds the all-time record for the highest total number of customer discovery interviews in the history of the I-Corps program.

NeuralRad
Brain